Question : A 65-year-old man with chronic systolic heart failure (HFrEF) is started on medical therapy. Which of the following drugs has been shown to reduce mortality in HFrEF? Options: A. Furosemide B. Digoxin C. ACE inhibitors (e.g., Enalapril) D. Nitrates alone ✅ Answer: C. ACE inhibitors (e.g., Enalapril) Explanation : HFrEF (EF <40%) management includes drugs that improve survival, reduce hospitalization, and relieve symptoms. ACE inhibitors / ARBs: Reduce mortality and morbidity. Decrease afterload, inhibit maladaptive RAAS activation, reduce LV remodeling. Beta-blockers (e.g., Carvedilol, Metoprolol succinate): Also improve survival in chronic HFrEF. Reduce sympathetic overdrive, prevent arrhythmias, improve EF over time. Mineralocorticoid receptor antagonists (e.g., Spironolactone): Reduce mortality in selected patients with HFrEF (EF ≤35%). Furosemide (loop diuretic): Symptomatic relief (reduces congestion) but does not improve survival. Digoxin : Improves symptoms a...
MedMCQDaily provides daily medical MCQs with explanations for NEET PG, FMGE, and clinical exam preparation. Learn, revise, and test your knowledge.